$DT -Cowen raises Dynatrace target to $68 from $62 Buy - $DUOL -Goldman raises Duolingo target to $135 from $114 Neutral - $EFX -RBC downgrades Equifax stock rating on -Cites mortgage weakness concerns -Raises target to $189 from $177 ca.investing.com/news/stock-…

$DDOG -Oppenheimer raises Datadog target to $330 from $300 Outperform -Cowen maintains $300 target Buy - $DEO -Morgan Stanley raises Diageo target to $83 from $76 Underweight - $DKNG -Stifel lowers DraftKings target to $32 from $36 Buy - $DOCN -UBS raises DigitalOcean target to $165 from $125 Neutral

$DARE -Ladenburg Thalman initiates Dare Bioscience coverage at Buy -Sets $2 target - $DAVE -Monness Crespi & Hardt initiate Dave coverage at Neutral ahead of earnings -The analyst cited several risk factors including an open Department of Justice case and Dave’s guarantee of its one funding bank’s receivables investing.com/news/analyst-r…

$CZR -Susquehanna maintains Caesars Neutral rating -The firm lowered its third-quarter 2026 estimates for the casino operator while keeping the price target unchanged at $31 investing.com/news/analyst-r…

$CTSH -JPMorgan raises Cognizant target to $78 from $67 Overweight -Wells Fargo raises target to $77 from $67 Overweight - $CVLT -Cantor Fitzgerald raises Commvault target to $171 from $132 Neutral -Jefferies raises target to $170 from $130 Hold

$CRWV -Raymond James lowers CoreWeave target to $75 from $125 -Cites AI spending concerns -Reiterates Outperform rating investing.com/news/analyst-r…

$CRCL Mizuho lowers Circle Internet target to $43 from $45 -Warns AI agents could hurt USDC demand -Maintains Underperform rating finance.yahoo.com/markets/cr…

$COSM -Noble Capital initiates Cosmos Health coverage at Outperform -The firm said the expanding U.S. direct-to-consumer operations could become an increasingly important driver of earnings growth -Sets $1.40 target investing.com/news/analyst-r…

$CMCSA -Freedom Broker lowers Comcast target to $25 from $29 Neutral - $COIN -JPMorgan raises Coinbase target to $185 from $148 Overweight

$CLYM -Guggenheim reiterates Climb Bio Buy rating on kidney drug data -Highlights budoprutug, an anti-CD19 treatment for primary membranous nephropathy -Maintains $35 target investing.com/news/analyst-r…

$CB -UBS raises Chubb target to $380 from $369 Neutral - $CELH -JPMorgan lowers Celsius target to $48 from $52 Overweight - $CHYM -Monness Crespi & Hardt initiate Chime Financial coverage with a Neutral rating investing.com/news/analyst-r…

$BTDR -Cantor Fitzgerald reiterates Bitdeer $18 target Overweight - $CART -Citizens JMP raises Maplebear target to $65 from $60 Market Outperform - $CAT -Wells Fargo lowers Caterpillar target to $840 from $1155 Overweight -UBS raises target to $750 from $925 Neutral

$BMY -Piper Sandler lowers Bristol Myers target to $78 from $82 Overweight - $BPOP -Piper Sandler lowers Popular target to $190 from $198 Overweight - $BROS -UBS lowers Dutch Bros target to $75 from $85 Buy - $BSX -Stifel lowers Boston Scientific target to $55 from $60 Buy

$BETR -Needham raises Better Home & Finance target to $22 from $17 Buy - $BIDU -Bank of America lowers Baidu target to $132 from $141 Buy - $BLDR -Loop Capital lowers Builders FirstSource target to $62 from $90 Downgrades to Hold from Buy -Stifel target to $55 from $65 Hold

$BCC -Loop Capital downgrades Boise Cascade to Hold from Buy Lowers target to $85 from $98 - $BE -Evercore reiterates Bloom Energy $350 target Outperform -Barclays raises target to $316 from $308 = Weight -Wells Fargo raises target to $182 from $176 = Weight

$BDAI Biddance AI SystemsAnnounces First Half of Fiscal Year 2026 Results - Higher hardware sales lifted revenue, but lower gross margin and increased operating expenses accompanied a wider first-half loss. stocktitan.net/news/BDAI/bid…

$BAH -Stifel raises Booz Allen Hamilton target to $112 from $110 Buy -Cowen raises target to $95 from $77 Upgrades to Buy from Hold -Citi raises target to $88 from $77 Neutral -UBS raises target to $86 from $79 Neutral -BNP Paribas raises target to $85 from $70 Neutral -Bank of America lowers target to $68 from $75 Underperform

$AZO -Bank of America resumes AutoZone coverage with a Buy rating Sets $3800 target -Cowen reiterates Buy rating Maintains $3400 target - ca.investing.com/news/stock-…